AzTrials
AzTrials

Urinary Bladder Neurogenic DysfunctionNCT01297660

Neuro-urological Outcome After Spinal Cord Injury

An observational study of Urinary Bladder Neurogenic Dysfunction, run by Balgrist University Hospital at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Most patients with spinal cord injury suffer from bladder dysfunction which may - especially in the long-term - impair renal function. Improved treatment during the last decades improved life expectancy and quality of life. This study evaluates the bladder function in the long-term after spinal cord injury. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Urinary Bladder Neurogenic Dysfunction
What is being tested?
Video-urodynamic examination
How many people
55 participants
Where
1 siteSwitzerland
Study dates
Jan 2010to Sep 2010
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Ages Eligibility: minimum 18 years old Genders Eligibility: female and male

Who may be able to join

  • Spinal cord injury for at least 5 years
  • Neurogenic lower urinary tract dysfunction
  • Written informed consent

Who cannot join

  • Lower urinary tract dysfunction due to other causes than spinal cord injury

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital

    Zurich, Canton of Zurich, 8008

Other trials in Switzerland

About this study

Most patients with spinal cord injury suffer from bladder dysfunction which may - especially in the long-term - impair renal function. Improved treatment during the last decades improved life expectancy and quality of life. This study evaluates the bladder function in the long-term after spinal cord injury.

Read the detailed description

Bladder dysfunction is a common consequence of spinal cord injury and depends on the completeness and the level of the lesion. Patients with suprasacral injury usually suffer from neurogenic detrusor overactivity mostly combined with detrusor sphincter dyssynergia. Without adequate treatment, this adverse combination puts the upper urinary tract at risk due to high intravesical pressure often causing vesico-ureteral reflux. Based on improved therapeutic options in the last decades, life expectancy and quality of life constantly increased in spinal cord injury patients. The investigators aim to evaluate the bladder function in the long-term after spinal cord injury.

Being tested
Video-urodynamic examination
Keywords
neurogenic detrusor overactivity, detrusor sphincter dyssynergia, compliance, video urodynamic, spinal cord injury
Medical subject headings
Urinary Bladder, Neurogenic, Patient Compliance, Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Video-urodynamic examinationOther

Study groups in NCT01297660
Study groupRoleWhat they receive
patients with SCI for at least 5 yearsAges Eligibility: minimum 18 years Genders Eligibility: female and male
Receives: Other: Video-urodynamic examination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Urodynamic evaluation

    Max. cystometric capacity, compliance, detrusor leak point pressure

    Measured: 5 years after SCI, yearly thereafter (participants are followed until death)

Secondary outcomes (2)
  1. secondary complications

    recurrent tract infection, deterioration of the upper urinary tract

    Measured: 5 years after SCI, yearly thereafter (participants are followed until death)

  2. imaging of the upper urinary tract

    videocystography, ultrasound

    Measured: 5 years after SCI, yearly thereafter (participants are followed until death)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2011 (estimated)
  2. Study startJan 2010
  3. Primary completionSep 2010
  4. Study completionSep 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01297660
Sponsor's protocol ID
KEK-2010-0207/01
Status last verified
Dec 2016
First submitted
16 Feb 2011
Last updated
16 Dec 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Urinary Bladder Neurogenic Dysfunction, run by Balgrist University Hospital at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Urodynamic evaluation (time frame: 5 years after SCI, yearly thereafter (participants are followed until death)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Dec 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in